[
  {
    "question": "How is HIV diagnosed?",
    "answer": "HIV is typically diagnosed through a combination of laboratory tests, including:\n\n1. **Rapid tests**: These are point-of-care tests that detect HIV antibodies in blood or oral fluid. They provide quick results, usually within 20-30 minutes.\n2. **Enzyme-linked immunosorbent assay (ELISA)**: This test detects HIV antibodies in blood and is often used as a follow-up to a rapid test.\n3. **Western blot**: This test confirms the presence of HIV antibodies and is often used to confirm a positive ELISA result.\n4. **Nucleic acid tests (NAT)**: These tests detect the genetic material of the virus itself, rather than antibodies, and can detect HIV earlier than antibody tests.\n5. **Combination tests**: Some tests combine multiple technologies, such as antigen/antibody tests, which can detect both HIV antibodies and p24 antigen (a protein on the virus).\n\nIt's essential to note that a diagnosis of HIV is typically confirmed by a combination of these tests, and a healthcare provider will interpret the results in the context of the patient's medical history and symptoms.",
    "true_answer": "HIV is diagnosed through HIV testing. There are three types of tests used to diagnose HIV infection: antibody tests, antigen/antibody tests, and nucleic acid tests (NATs). How soon each test can detect HIV infection differs, because each test has a different window period. The window period is the time between when a person may have been exposed to HIV and when a test can accurately detect HIV infection. Window periods for different HIV tests are the followings: Antibody tests can usually detect HIV 23 to 90 days after exposure. Most rapid tests and self-tests are antibody tests. A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure. An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A NAT can usually detect HIV 10 to 33 days after exposure. When an HIV test is positive, a follow-up test will be conducted for confirmation. Sometimes people will need to visit a health care provider to take a follow-up test using another blood sample. Other times, the follow-up test may be performed in a lab using the original blood sample to ensure that the first positive result wasn\u2019t a false positive"
  },
  {
    "question": "What are the different stages of HIV?",
    "answer": "The different stages of HIV infection are:\n\n1. **Acute HIV Infection**: The initial stage, occurring 2-4 weeks after exposure, where the virus replicates rapidly and the person may experience flu-like symptoms.\n2. **Clinical Latency** (also known as Chronic HIV Infection): A long period where the virus is still active, but at low levels, and the person may not show symptoms. This stage can last for years.\n3. **AIDS (Acquired Immunodeficiency Syndrome)**: The most advanced stage, where the immune system is severely damaged, and the person is susceptible to opportunistic infections and certain cancers.\n\nIt's worth noting that with effective antiretroviral therapy (ART), people living with HIV can manage the disease and prevent progression to AIDS.",
    "true_answer": "The different stages of HIV are either defined as three: (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS); or four: (1) acute HIV infection, (2) asymptomatic stage, (3) symptomatic HIV, and (4) Late-stage HIV or AIDS."
  },
  {
    "question": "How is HIV transmitted?",
    "answer": "HIV (Human Immunodeficiency Virus) is primarily transmitted through:\n\n1. **Unprotected sex** (vaginal, anal, or oral) with an infected person.\n2. **Sharing needles** or syringes contaminated with infected blood.\n3. **Mother-to-child** transmission during pregnancy, childbirth, or breastfeeding, if the mother is not on effective treatment.\n4. **Blood transfusions** from an infected donor, although this is rare in countries with strict blood screening protocols.\n5. **Occupational exposure**, such as needlestick injuries, in healthcare settings.\n\nIt's essential to note that HIV is not transmitted through casual contact, such as hugging, shaking hands, or sharing food and drinks.",
    "true_answer": "HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It can also spread from a mother to her baby."
  },
  {
    "question": "What comorbidities are common among people living with HIV?",
    "answer": "People living with HIV are at increased risk for several comorbidities, including:\n\n1. Cardiovascular disease\n2. Hepatitis B and C coinfection\n3. Mental health disorders (e.g., depression, anxiety)\n4. Chronic kidney disease\n5. Osteoporosis\n6. Certain cancers (e.g., Kaposi's sarcoma, lymphoma)\n7. Neurocognitive disorders\n8. Lipodystrophy and metabolic syndrome\n9. Chronic lung disease (e.g., COPD)\n10. Liver disease\n\nThese comorbidities can be related to the HIV infection itself, antiretroviral therapy (ART) side effects, or shared risk factors. Regular screening and management of these comorbidities are essential for overall health and well-being in people living with HIV.",
    "true_answer": "The most common comorbidities amongst patients with HIV include: diabetes mellitus, cardiovascular disease (CVD, e.g. hypertension), respiratory diseases (e.g. chronic obstructive pulmonary diseases and pneumonia), and hepatic diseases (hepatitis B and C). Liver disease, renal disease, substance dependence and abuse, sexually transmitted infections (herpes simplex, syphilis, gonorrhoea and Mycoplasma genitalium) and psychiatric disorders (including depression, anxiety, schizophrenia and cognitive impairment) are also greater among HIV-positive individuals."
  },
  {
    "question": "How can HIV be prevented?",
    "answer": "HIV prevention methods include:\n\n1. **Using condoms** correctly and consistently during sex.\n2. **Pre-exposure prophylaxis (PrEP)**: taking daily medication for high-risk individuals.\n3. **Post-exposure prophylaxis (PEP)**: taking medication within 72 hours after potential exposure.\n4. **Getting tested** and knowing your status, as well as your partner's.\n5. **Avoiding sharing needles** or equipment for injecting drugs.\n6. **Antiretroviral therapy (ART)** for HIV-positive individuals to suppress the virus, making transmission less likely.\n\nThese methods can significantly reduce the risk of HIV transmission.",
    "true_answer": "HIV prevention involves several key strategies. To reduce the risk of getting HIV, it is important to use condoms correctly every time during sex. For individuals who inject drugs, avoiding drug use altogether is recommended, but if drugs are used, only sterile injection equipment and water should be used, and equipment should never be shared with others. Pre-exposure prophylaxis (PrEP) is an option for those at risk of HIV, involving either a daily HIV medicine or an injectable HIV medicine every two months to lower the risk of infection through sex or injection drug use. For those already living with HIV, taking antiretroviral therapy (ART) as prescribed can reduce the amount of HIV in the blood to undetectable levels, preventing transmission to sexual partners. To prevent perinatal transmission, individuals with HIV who take HIV medicine as prescribed throughout pregnancy and childbirth reduce the risk of passing HIV to their baby to less than 1%. Additionally, in cases where one partner has HIV, PrEP can help protect both the individual and their baby while trying to conceive, during pregnancy, or while breastfeeding."
  },
  {
    "question": "How frequently ART must be taken?",
    "answer": "Antiretroviral therapy (ART) for HIV typically requires taking medication daily, with most regimens involving one or more pills taken once or twice a day, every day, without interruption. Adherence to the prescribed regimen is crucial for viral suppression and preventing drug resistance.",
    "true_answer": "Antiretroviral therapy (ART) must be taken as a pill every day or as a shot once every month or two months."
  },
  {
    "question": "How can we prevent Perinatal transmission of HIV?",
    "answer": "Preventing perinatal transmission of HIV involves several steps:\n\n1. **HIV testing**: All pregnant women should be tested for HIV.\n2. **Antiretroviral therapy (ART)**: HIV-positive pregnant women should receive ART to suppress the virus.\n3. **Scheduled cesarean delivery**: For women with high viral loads, a scheduled C-section can reduce transmission risk.\n4. **Avoid breastfeeding**: HIV-positive mothers should not breastfeed to prevent postnatal transmission.\n5. **Antiretroviral prophylaxis**: Newborns of HIV-positive mothers should receive antiretroviral prophylaxis after birth.\n\nThese interventions can significantly reduce the risk of perinatal HIV transmission.",
    "true_answer": "To prevent perinatal transmission of HIV, pregnant women should take antiretroviral therapy (ART) throughout pregnancy and childbirth. ART throughout pregnancy and childbirth reduces the chances of perinatal transmission of HIV to less than 1%."
  },
  {
    "question": "What are the main cell types infected with HIV?",
    "answer": "The main cell types infected with HIV are:\n\n1. CD4+ T cells (also known as T helper cells)\n2. Macrophages\n3. Dendritic cells\n\nThese cells all have CD4 receptors on their surface, which HIV uses to gain entry into the cells.",
    "true_answer": "The main cell types found to be infected with HIV are CD4+ T lymphocytes and macrophage-lineage cells."
  },
  {
    "question": "What is the difference between HIV and AIDS?",
    "answer": "HIV (Human Immunodeficiency Virus) is the virus that attacks the body's immune system, specifically the CD4 cells. AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV infection, where the immune system is severely damaged, and the body is more susceptible to opportunistic infections and certain cancers.\n\nIn other words, all people with AIDS have HIV, but not all people with HIV have AIDS. With proper treatment, people with HIV can live for many years without developing AIDS.",
    "true_answer": "HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. AIDS stands for acquired immunodeficiency syndrome, the most advanced stage of HIV infection."
  },
  {
    "question": "How is HIV not transmitted?",
    "answer": "HIV is not transmitted through:\n\n* Casual contact (shaking hands, hugging, sharing food or drinks)\n* Air or water\n* Insect bites\n* Saliva, sweat, or tears (unless mixed with blood)\n* Toilet seats or shared toiletries\n* Sharing personal items like razors or toothbrushes (unless they have blood on them)\n\nIt's also important to note that HIV cannot survive long outside the human body, so it cannot be transmitted through inanimate objects.",
    "true_answer": "You cannot get HIV from: Air or water. Saliva, tears, sweat, feces, or urine that is not mixed with the blood of a person with HIV. Casual contact with a person who has HIV, such as a handshake, a hug, or a closed-mouth kiss. Contact with objects, such as toilet seats, doorknobs, or dishes used by a person who has HIV. Mosquitoes, ticks, or other biting insects. Other sexual activities that do not involve the exchange of body fluids (for example, touching). HIV can\u2019t be passed through healthy, unbroken skin."
  },
  {
    "question": "What is known about the switch that occurs between patients with latent HIV and active infection?",
    "answer": "The switch from latent HIV to active infection is a complex process, not yet fully understood. However, research suggests that it involves the reactivation of latent HIV reservoirs, often due to fluctuations in the immune system or changes in the cellular environment.\n\nLatent HIV reservoirs are populations of infected cells, typically memory CD4+ T cells, that harbor the virus in a dormant state. These cells are not actively producing viral particles, but can be reactivated to produce infectious virus.\n\nThe reactivation of latent HIV is thought to be triggered by various factors, including:\n\n1. Immune activation: Inflammation, immune responses to other infections, or antigen presentation can reactivate latent HIV.\n2. Cellular stress: Cellular stress, such as that caused by cytokines or chemokines, can also trigger reactivation.\n3. Epigenetic changes: Changes in the epigenetic landscape of the host cell can influence the expression of latent HIV.\n\nThe exact mechanisms underlying the switch from latency to active infection are still being studied, and more research is needed to fully understand this process.",
    "true_answer": "The switch between latent and active HIV infection is primarily driven by the activation of HIV provirus within latently infected cells. Latent HIV infection occurs when the virus integrates its genetic material into the host cell's DNA, allowing the virus to persist in a dormant state. In latent infection, viral replication and gene expression are minimal or absent, and the infected cells remain functionally normal. This form of infection is responsible for the long-term persistence of HIV in individuals, even when systemic viral replication is suppressed with antiretroviral therapy (ART). The switch to active HIV infection occurs when the provirus becomes transcriptionally active; this is often triggered by extracellular signals or events that activate the host cell . One possible mechanism for the switch involves the binding of cellular transcription factors, such as nuclear factor kappa B (NF-\u03baB) and nuclear factor of activated T-cells (NFAT), to the HIV long terminal repeat (LTR) region, resulting in the activation of proviral transcription. Other factors that can contribute to the switch include cytokines, chemokines, and cellular activation signals. This transition between latent and active HIV infection plays a critical role in the pathogenesis of the disease, as it is during periods of active infection that the virus replicates and spreads to new cells, ultimately leading to the progressive decline of the host immune system . Understanding the molecular mechanisms involved in the switch from latent to active HIV infection could help inform the development of novel therapeutic strategies aimed at targeting and eliminating latently infected cells, which represent a major obstacle to achieving a cure for HIV."
  }
]